Medicare Enrolled
Dr. Mark Daniel, M.D.
Family Medicine · Elberton, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Daniel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Daniel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Daniel
Dr. Mark Daniel is a family medicine specialist in Elberton, GA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Daniel performed 304 Medicare services across 216 unique beneficiaries.
Between the years covered by Open Payments, Dr. Daniel received a total of $11,342 from 58 pharmaceutical and/or device companies across 716 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Daniel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ 304 Medicare services
$11,342 industry payments
Medicare Practice Summary
Medicare Utilization ↗304
Medicare services
Bottom 30% in GA for family medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
216
Unique beneficiaries
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~14 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
46 | $60 | $184 |
| Routine 12-lead electrocardiogram (ECG) A test that records the electrical activity of the heart using at least 12 leads to produce a tracing. |
42 | $3 | $58 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
42 | $56 | $118 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
37 | $13 | $75 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
37 | $30 | $80 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
23 | $2 | $25 |
| Multiplex PCR test for SARS-CoV-2 and influenza A and B A laboratory test that uses a multiplex amplified probe technique to detect the presence of SARS-CoV-2 (COVID-19) and influenza virus types A and B in a single sample. |
19 | $69 | $70 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
17 | $3 | $35 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
16 | $6 | $51 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
13 | $99 | $290 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
12 | $61 | $165 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,342
Total received (2018-2024)
Avg $1,620/year across 7 years
Top 4% in GA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
716
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,301 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$41 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,915
2023
$1,792
2022
$1,712
2021
$2,154
2020
$980
2019
$1,336
2018
$1,452
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Otsuka America Pharmaceutical, Inc.
$200
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$163
ABBVIE INC.
$161
SHIELD THERAPEUTICS INC
$148
Lilly USA, LLC
$145
Novo Nordisk Inc
$141
PFIZER INC.
$112
Boehringer Ingelheim Pharmaceuticals, Inc.
$105
Astellas Pharma US Inc
$104
AstraZeneca Pharmaceuticals LP
$78
Novartis Pharmaceuticals Corporation
$75
Corcept Therapeutics
$69
Bayer Healthcare Pharmaceuticals Inc.
$64
GlaxoSmithKline, LLC.
$57
Abbott Laboratories
$38
SANOFI-AVENTIS U.S. LLC
$38
Exact Sciences Corporation
$37
Vanda Pharmaceuticals Inc.
$26
Amgen Inc.
$24
Xeris Pharmaceuticals, Inc.
$20
Mylan Specialty L.P.
$18
Axsome Therapeutics, Inc.
$17
Cranial Technologies, Inc
$17
IDORSIA PHARMACEUTICALS US INC
$16
Actelion Pharmaceuticals US, Inc.
$15
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$15
Merck Sharp & Dohme LLC
$14
Top 3 companies account for 27.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,255
AstraZeneca Pharmaceuticals LP
$999
Boehringer Ingelheim Pharmaceuticals, Inc.
$738
Boston Scientific Corporation
$733
ABBVIE INC.
$515
AbbVie Inc.
$507
Lilly USA, LLC
$498
PFIZER INC.
$478
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$465
GlaxoSmithKline, LLC.
$464
Amgen Inc.
$453
Novartis Pharmaceuticals Corporation
$377
SANOFI-AVENTIS U.S. LLC
$343
Otsuka America Pharmaceutical, Inc.
$342
Janssen Pharmaceuticals, Inc
$324
Bayer Healthcare Pharmaceuticals Inc.
$195
Astellas Pharma US Inc
$186
Shield Therapeutics Inc
$155
SHIELD THERAPEUTICS INC
$148
Lundbeck LLC
$144
Teva Pharmaceuticals USA, Inc.
$136
Bayer HealthCare Pharmaceuticals Inc.
$133
Takeda Pharmaceuticals U.S.A., Inc.
$132
Corcept Therapeutics
$130
Amarin Pharma Inc.
$127
Merck Sharp & Dohme Corporation
$126
Kowa Pharmaceuticals America, Inc.
$124
Esperion Therapeutics, Inc.
$93
IDORSIA PHARMACEUTICALS US INC
$93
Nestle HealthCare Nutrition Inc.
$84
Merck Sharp & Dohme LLC
$72
Allergan Inc.
$63
Exact Sciences Corporation
$62
Biohaven Pharmaceutical Holding Company Ltd.
$60
Synergy Pharmaceuticals Inc
$59
Genentech USA, Inc.
$53
E.R. Squibb & Sons, L.L.C.
$52
Biogen, Inc.
$50
Xeris Pharmaceuticals, Inc.
$43
Abbott Laboratories
$38
Vanda Pharmaceuticals Inc.
$26
BOSTON SCIENTIFIC CORPORATION
$19
Ironwood Pharmaceuticals, Inc
$19
Mylan Specialty L.P.
$18
Axsome Therapeutics, Inc.
$17
AbbVie, Inc.
$17
Horizon Therapeutics plc
$17
Cranial Technologies, Inc
$17
DEXCOM, INC.
$16
Melinta Therapeutics, Inc.
$16
Hikma Pharmaceuticals USA
$15
Eyevance Pharmaceuticals LLC
$15
Actelion Pharmaceuticals US, Inc.
$15
Purdue Pharma L.P.
$15
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$15
Biohaven Pharmaceuticals, Inc.
$12
Eisai Inc.
$12
Allergan, Inc.
$11
Top 3 companies account for 26.4% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ACCRUFER · ADUHELM · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · Aimovig · Amitiza · Auvelity · BELSOMRA · BEXSERO · BREZTRI · BREZTRI AEROSPHERE · BYSTOLIC · Baxdela · CAPLYTA · CHANTIX · COMIRNATY · Cologuard Collection Kit · DALIRESP · DALVANCE · DEXCOM G6 TRANSMITTER · DUZALLO · Dayvigo · Doc Band · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · FANAPT · FARXIGA · FASENRA · FREESTYLE LIBRE 3 · GARDASIL · GARDASIL 9 · GENERAL PAIN MANAGEMENT · GVOKE HYPOPEN · HUMIRA · Humira · INVOKANA · JANUMET · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LINZESS · LYRICA · Levemir · Livalo · MOUNJARO · MYRBETRIQ · Mitigare · Myrbetriq · NEXLETOL · NURTEC ODT · OFEV · Otezla · Ozempic · PNEUMOVAX 23 · PREMARIN · PREVNAR - 13 · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · RAYOS · RELISTOR ORAL · REXULTI · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMPROIC · Saxenda · TEFLARO · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TZIELD · Tobradex ST · Tresiba · Trulance · UBRELVY · UPTRAVI · Uloric · VRAYLAR · VYEPTI · Vascepa · Veozah · Victoza · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO · XIFAXAN · Xofluza · YUPELRI · ZENPEP · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for family medicine in GA.
Geographic Context
Family medicine physicians within 10 mi
49
Per 100K population
248.4
County median income
$49,727
Nearest hospital
ELBERT MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Daniel is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 4% of GA peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Daniel experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Daniel performed 46 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Daniel receive payments from pharmaceutical companies?
Yes. Dr. Daniel received a total of $11,342 from 58 companies across 716 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Daniel's costs compare to other family medicine physicians in Elberton?
Dr. Daniel's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Daniel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Elberton
Browse family medicine physicians in Elberton ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in GA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in GA
Which GA family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology